This is an open access article under the terms of the Creat ive Commo ns Attri bution-NonCo mmerc ial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Abstract Background: Specialty societies, such as the International Society on Thrombosis and Haemostasis (ISTH), are a key source of support for clinical and scientific communities, through the provision of educational activities, tools, and resources to support evidence-based care and high-quality, relevant basic science and clinical research.
| INTRODUCTION
Hemostatic disorders such as thrombosis and bleeding conditions occur when the process for normal hemostatic equilibrium is altered. 1 Basic science research conducted on coagulation mechanisms has greatly improved scientific knowledge of the complex pathophysiology of coagulation disorders. 2, 3 The past decade has seen significant advancements in technology used to study molecular and pathophysiologic processes in hemostatic disorders. 4 In the field of thrombosis and hemostasis (T&H), basic science and clinical research has led to considerable advancements in clinical therapies, [5] [6] [7] including the development of long-acting coagulation factors and gene therapy for patients with hemophilia, 8 new approaches and agents for anticoagulation to prevent or treat thrombosis, 9 and new insights into the connection between coagulation, inflammation, and immunity. 10 These advances have led to an increasingly complicated decision-making process, reflected by the complex impact that hemostatic imbalance can have on the complement system, immunity, and inflammation and, therefore, the management of hemostatic disorders. 11, 12 This situation is compounded, in some instances, where access to even basic laboratory testing and medications is limited, 13 as are opportunities to access the latest scientific knowledge, tests, devices, or medications, compromising provision of optimal clinical care. 14 Given this rapidly evolving context, educational activities are needed to ensure optimal knowledge dissemination to T&H professionals. Specialty societies are in a position to provide support and educational offerings that facilitate access to appropriate resources and tools that enable the production of high-quality, relevant, basic science and clinical research. However, there is currently a lack of research identifying the specific challenges faced by clinicians and researchers -information that is necessary to develop impactful, evidence-based solutions.
Though it is increasingly recognized that educational offerings must be designed on the basis of the learners' needs, 15, 16 often these needs are presumed, rather than objectively determined. To better understand the needs of the T&H community, the International Society on Thrombosis and Haemostasis (ISTH) conducted a needs assessment of its membership and other professionals in the field. The study objective was to identify areas where the T&H community, including ISTH members, faced challenges and could benefit from the support of a specialty society.
| METHODS
The ISTH enlisted AXDEV to carry out a mixed-methods assessment of the needs of the T&H community. Participants were both members and nonmembers, whose professions included physicians, clinical researchers, basic science researchers, residents, fellows, doctoral and postdoctoral students, and industry representatives.
Collection of qualitative and quantitative data was done in 3 consecutive phases. Prior to the first data collection phase, a literature review was conducted to determine the areas of exploration and identify challenges faced by clinicians or researchers. These areas were discussed and refined with subject matter experts to inform the design of the interview guides.
The KSA (knowledge, skills, and attitude) model 17 was used to structure the design of data collection tools. Behavioral and educational researchers in the field of health care (co-authors SM, PL, and MP) executed the study design and data collection, while subject matter experts (co-authors CM, SS, SMR, JHM, TR, and IP) provided scientific and clinical expertise in the field of T&H. Data were interpreted by both groups.
| Phase 1: Individual interviews
Individuals from 7 different professions and specialties participated in semistructured 45-minute interviews.
Interviews consisted of open-ended questions described in Data S1, to prompt discussion and gain an in-depth understanding of participants' perspectives on themes predetermined in the study design phase. 18 Interviews were conducted in English by trained interviewers (including PL, MP, and SM), with questions adapted to the participants' occupation. The most substantive themes that emerged from the qualitative analysis were discussed with subject matter experts and used to inform the phase 2 online survey. 
| Phase 2: Online survey
Survey questions were developed by educational researchers and reviewed by subject matter experts to ensure clinical relevance and validity. The survey aimed to validate the extent to which previously identified challenges or specific perspectives were represented in a larger sample of participants. Response scales and survey sections are described in Data S1. Survey items and examples of questions can be found in Tables 2 and 3 . Eligible participants were categorized by their reported profession, and subsequent questions were adjusted accordingly. Surveys were deployed in English only, using vocabulary that is accessible to individuals with another first language. Phase 2 data were then analyzed and triangulated with qualitative data (phase 1) and literature review findings.
| Phase 3: Discussion groups
Findings from phases 1 and 2 were presented during 90-minute discussion groups at the ISTH 2017 Congress (July 8-13, 2017). These groups included participants from various countries and diverse professions, and aimed to obtain insights as well as potential explanations for the identified challenges. The most substantive themes that emerged from these discussion groups were used in the final triangulation of data, leading to the key findings (see analysis section).
| Recruitment and inclusion criteria
Potential participants were contacted via the ISTH database. Email invitations were sent to approximately 20 000 professionals (nonmembers and ISTH members from 24 selected countries). Invitations directed potential participants to a secure Web page to complete a screener.
Participants who categorized themselves as clinical physicians or as researchers had to spend at least 50% of their professional time caring for patients or in basic science or clinical research activities, respectively. For the fellow/student/resident category, potential participants had to have reached their fourth year of medical school or to be engaged in doctoral or postdoctoral studies. Industry representatives had to be currently working within the pharmaceutical, biotechnology, or medical devices industry and must have been doing so for at least 2 years. Nurses were excluded, as a separate needs assessment in their profession was being conducted simultaneously. 19 Eligible participants had to be practicing in the targeted countries within each region (see Table 1 legend). Countries were selected to reflect the membership distribution of ISTH and to represent a range of experiences while increasing the comparability of health systems and professional practices. All eligible participants were directed to an informed consent agreement, then either to the survey (phase 2) or to an availability form (phases 1 and 3).
A purposive sampling strategy was used to increase the representativeness of the T&H community by targeting a variety of practice settings (community-based, academic, specialized centers), countries, and years of experience. All subspecialties of clinicians or researchers in the field of T&H were included.
| Qualitative analysis
Qualitative data obtained from the semistructured interviews (phase 1) and discussion groups (phase 3) were analyzed using a directed qualitative content approach. 20 Analysis began with the creation of a coding structure based on preidentified areas of exploration, with more themes added during the coding process. Multiple behavioral and educational researchers coded the transcripts using NVIVO software (QSR International, Cambridge, MA). Interviews were transcribed and coded until the coders unanimously determined that data saturation was reached. Data saturation is defined as a criterion for discontinuing data analysis when no new themes are identified that require creating new categories within the coding structure. 21, 22 The most substantive themes that emerged were organized according to each participant's occupational subgroup.
| Quantitative analysis
Answers to the online survey (phase 2) were analyzed using SPSS software (version 22.0, IBM Corporation, Armonk, NY) and consisted of frequency tables and cross-tabulations. Participants' answers were dichotomized to identify potential areas of improvement, similar to methods used in previous needs assessments. 23, 24 More detail on this process is provided in Data S1.
Pearson chi-squares with a 0.05 level of significance were used to identify differences between subgroups, based on the participant years of practice/research (ie, ≤10 vs. ≥11 years) and their main (but not exclusive) domain of practice (ie, thrombosis, bleeding, or both equally).
| Final analysis and triangulation of data
Triangulation was performed by combining data gathered using qualitative and quantitative methods and from a variety of sources (clinicians, researchers, industry representatives, fellows/residents/ students). Convergence and corroboration were sought as a way to minimize biases inherent in using only a single method 25, 26 and to increase the validity and trustworthiness of the findings. [27] [28] [29] [30] 
| Ethics
This study received ethics approval from an independent ethics review board (VERITAS, Canada). Individual informed consent was obtained before participation in this study. Participants were entered into a draw for a chance to win registrations to the ISTH 2017
Congress and ISTH memberships.
| RESULTS
Of the 1612 members of the T&H community who responded to the study invitations (response rate, 8%), 468 were eligible participants (232 clinicians, 145 basic science or clinical researchers, 59 fellows/residents/students, 32 industry representatives or others).
Individual interviews (phase 1) were conducted with 45 participants, and online surveys (phase 2) were completed by 404 participants.
Results from phases 1 and 2 were discussed with 19 participants in 3 live discussion groups (phase 3; Table 1 ).
Ten key themes that emerged from the triangulated analysis were identified as areas where the T&H community could benefit from additional support ( Figure 1 ) and are detailed in the following sections.
| Findings related to the diagnosis and testing of coagulation disorders

| Challenges in thrombosis risk assessment
Conducting a clinical risk evaluation in thrombosis emerged as a challenge for participants with a clinical practice. As shown in Table 2 , normalized ratio results were reported as suboptimal by 22% and 14% of clinicians, respectively ( Table 2) . A greater proportion of clinicians with less experience reported suboptimal skills interpreting D-dimer tests, compared to those with more experience (31% vs.
17%, P = 0.007).
| Challenges with genetic testing in thrombosis and bleeding disorders
The triangulated analysis identified genetic testing as an area where clinicians may benefit from educational interventions. Suboptimal knowledge of when to order genetic testing for thrombosis patients was reported by 31% of clinicians ( 
| Challenges with diagnosis of von Willebrand disease
Diagnosing von Willebrand disease (VWD) emerged as a challenging area for clinicians. A total of 35% of clinicians reported suboptimal knowledge of how to diagnose VWD ( Table 2 ). Whereas only a small proportion of clinicians practicing mainly in bleeding disorders reported suboptimal knowledge (6%), more than half (52%) of clinicians who practice mainly in thrombosis disorders and 28% of clinicians practicing equally in both conditions reported suboptimal knowledge (P < 0.001).
When asked about their skills in establishing a diagnosis of VWD, 38% of clinicians reported that their skills were suboptimal, with a higher proportion found in clinicians practicing mainly in thrombosis disorders (54%), compared to those practicing mainly in bleeding disorders (12%) or practicing equally in both (32%; P < 0.001). The skill gap was higher in less experienced clinicians, compared to those with more experience ( Table 2 , 47% vs. 33%; P = 0.024).
| Challenges with global assays in T&H disorders
Integrating the results of global assays to inform treatment decisions was reported as a challenge. Among all clinicians, 39% reported suboptimal skills using these results to guide treatment ( Table 2 ). In each of the 3 domains of practice, a similar proportion of clinicians reported suboptimal skills in this area.
F I G U R E 1 The 10 key themes that emerged from the triangulated analysis: areas where the T&H community could benefit from additional support Question: For each statement below, please select the number that best describes your level of knowledge, given your profession. Scale: 1 = Not acceptable given my profession; 3 = Acceptable but could be improved given my profession; 5 = Ideal given my profession. TA B L E 2 (Continued)
| Findings related to treatment decision making in T&H disorders
| Challenges with anticoagulants in specific patients
Challenges related to thromboprophylaxis regimens were also identified. Suboptimal knowledge of the type of thromboprophylaxis regimen to use, according to a patient profile, was reported by 28% of clinicians. In addition, 31% of clinicians reported suboptimal skills,
given their role, in determining treatment for VTE in cancer patients (Table 2) .
Patients with a thrombotic disorder in addition to a bleeding history also represented a treatment challenge. Suboptimal knowledge of the use of anticoagulant medication in patients with a history of bleeding episodes was reported by 34% of clinicians. This gap was higher among clinicians practicing mainly in bleeding disorders (40%) and those practicing equally in both domains (41%; P = 0.020).
Specifically, 31% of clinicians reported suboptimal knowledge of the correct timing to reinitiate anticoagulants in patients that have had a hemorrhagic episode. A higher proportion of less experienced clinicians reported having a knowledge gap in this area, as compared to more experienced clinicians (36% vs. 23%; P = 0.022). Skills in adjusting anticoagulant medication were reported as suboptimal by 32% of clinicians for patients who have had a severe bleeding episode and by 28% for patients who have had a nonsevere bleeding episode (Table 2 ).
| Challenges with preventive treatments in bleeding disorders
Suboptimal knowledge of treatment for bleeding episodes in people with hemophilia was reported by nearly half of participants (49%).
This knowledge gap was self-reported by a majority (72%) of clinicians mainly practicing in thrombosis and by 41% of participants practicing in both areas equally (P < 0.001). Suboptimal knowledge of long-term prevention of bleeding episodes in hemophilia patients was also selfreported by clinicians practicing in both domains equally (44%) and clinicians practicing mainly in thrombosis (75%; P < 0.001). This proportion was significantly higher among less experienced clinicians, as compared to those with more experience (62% vs. 47%; P = 0.018).
One third (33%) of clinicians reported suboptimal skills in deciding the type of prophylaxis treatment to use to prevent bleeding episodes. This proportion rose to 41% among less experienced clinicians, in contrast to 27% of more experienced clinicians (P = 0.019).
| Challenges around treatment of VWD
Knowledge of treatment options for VWD was reported as suboptimal by 65% of clinicians practicing mainly in thrombosis and 37% practicing equally in both domains (P < 0.001). A significantly higher proportion of less experienced clinicians than those with more experience also reported suboptimal knowledge of the treatment options for VWD (52% vs. 38%; P = 0.026).
A similar situation was found in the self-reported ability to decide on a treatment plan for patients with VWD, as 62% of clinicians practicing mainly in thrombosis and 39% practicing in both domains equally reported suboptimal skills in this area (P < 0.001), as did a higher proportion of less experienced than more experienced clinicians (54% vs. 38%, P = 0.010). Less experienced clinicians lacking confidence was a recurrent and emerging qualitative theme:
I think von Willebrand disease is hard. It's really hard to make a plan for a patient and if you talk to one doctor and he will tell you, "Oh, I will do this,"
and then you talk to somebody else and he will say, "I will do that. 
| Findings related to research in the T&H field
| Challenges around collaboration with and among researchers
Collaboration in the research community was among the reported challenges. Over half of researchers (52%) reported that collaborating with other researchers not directly in their area of expertise was difficult (Table 3) . Specifically, 39% of researchers perceived that it was difficult to collaborate with clinical researchers. From a list of 12 barriers to conducting research, a "lack of communication between basic science and clinical researchers" was the item most often selected ( Figure 2) .
A majority of basic science researchers (58%) reported that the creation of networking opportunities for T&H researchers should be given more importance. "Lack of communication between clinicians and clinical researchers" was among the top 3 barriers to optimal care most frequently selected by clinicians ( Figure 3 ). This barrier was more often selected by clinicians practicing mainly in thrombosis (38%) compared to those practicing mainly in bleeding disorders (15%) or equally in both domains (25%).
| Challenges in collaboration between teams to collect data from human subjects
Collecting human data in T&H research was reported as challenging.
Nearly half of researchers (46%) reported that data collection from patients was "difficult" or "very difficult" in the context of noninterventional studies; in the context of interventional studies, 41%
reported this as difficult.
A specific challenging facet of gathering human data was related to the communication and collaboration needed between physicians and nurses to collect human blood samples:
The main problem with such studies is that doctors just get to collect blood for the point of the study, and the biggest challenge is to make them collect blood in time, in those points that we study.
Clinical researcher, Russia [#43]
| Perception that basic science research in the field of T&H is not adequately promoted
A majority of researchers (67%) indicated that promoting and stimulating basic science research should be given more importance by the research community in the field of T&H. Specifically, better support of multisite and multicountry studies should be given more importance, according to 49% of researchers.
When asked which topics should be better promoted among the research community in T&H, researchers cited 2 topics: the relationship between immune response, inflammation, and coagulation (69%); and the link between cancer and thrombosis (63%) (see Table 3 for details).
| DISCUSSION
This mixed-methods study aimed to identify areas where the T&H community faced challenges and therefore could benefit from the support of a specialty society. Three broad challenge areas emerged:
TA B L E 3 Perceptions of T&H researchers
Survey questions
Researchers whose activities are more oriented toward… To the best of your knowledge, do you think these research aspects or topics should be given: 1. More importance; 2. The same importance; or 3. Less importance by the research community in the field of thrombosis and hemostasis? diagnosis and testing of coagulation disorders, treatment decision making, and researcher-specific challenges. Study results indicated that within these core areas, clinicians had a suboptimal level of skills and knowledge of issues outside their specialty area; clinicians with less experience reported greater challenges; and collaboration between stakeholders in T&H was challenging across subspecialties and professional roles.
This study provides a platform to discuss the consequences of these core challenges on health care systems and to consider the contextual factors that may have affected the findings. The present discussion articulates the potential root causes and implications of these findings. Some of the study findings underscore the need for further educational offerings on topics that are consistent with the required competencies of clinicians practicing in T&H, as reported in the clinical core curriculum developed by the ISTH. 31 Participants who work primarily in bleeding disorders reported challenges when conducting risk assessments for VTE and when deciding when to order (and how to interpret) genetic tests.
Conversely, those who specialize in thrombosis experienced challenges diagnosing and planning treatments for patients with VWD.
Participants in either specialization generally reported greater skill to confidence gaps pertaining to knowledge translation and grant writing and review. 33 Interestingly, these gaps were not observed in our study. This difference could be explained by the fact that this
Canadian study was conducted with research faculty only, whereas our study involved a broader research community.
Researchers also indicated that there is a need for the ISTH and the T&H community to better externally promote and support basic science research and to increase awareness of the crucial role basic science research plays in driving new treatments and clinical practices. 34
| Study limitations
Although this study identified key gaps in knowledge, skills, and attitude in T&H, future studies explaining the exact root causes of these gaps are warranted, especially at a local level. Data collected were based on self-reports rather than objective observational data.
The sample size was appropriate for this type of exploratory mixedmethods study; however, given that the total sample size was distributed across several regions and divided between clinicians and researchers, subgroup findings should be interpreted as indicators only. Perception of patients were not included in this initiative.
There is a risk of selection bias regarding both the participants in the different study phases and the initial choice of general areas to be presented in the interviews.
This study included but did not distinguish between participants from developed and developing countries, which poses limitations on how the findings should be generalized. In all instances, responses likely varied depending on the participants' access to research facilities or funding, their individual professional role, and the presence or absence of collaboration opportunities or an expert consensus on best practices.
Illustrative quotes from workshop participants were reported, but the exact profession and country of practice were not due to difficulties distinguishing the identity of a speaker from a recorded group discussion. 
| Conclusions
